potent, selective, oral FPR2 GPCR agonist

for heart failure prevent. / entered Ph. I in HV

from optimization of known ligand

J. Med. Chem., May 24, 2020

Kyorin Pharmaceutical / Bristol-Myers Squibb


BMS-986235/LAR-1219 is an FPR1-sparing FPR2-selective agonist intended to help resolve chronic inflammation/promote wound healing to prevent serious complications like heart failure. It’s a very efficient molecule and is orally efficacious…

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: